login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Y-MABS THERAPEUTICS INC (YMAB) Stock News
USA
- NASDAQ:YMAB -
US9842411095
-
Common Stock
8.61
USD
+0.02 (+0.23%)
Last: 9/15/2025, 8:00:02 PM
8.61
USD
0 (0%)
After Hours:
9/15/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
YMAB Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: Zacks Investment Research
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
3 months ago - By: Halper Sadeh LLC
- Mentions:
VRNT
DAY
WOW
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNT, DAY, WOW, YMAB on Behalf of Shareholders
3 months ago - By: Brodsky & Smith LLC
- Mentions:
VRNT
DAY
WOW
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verint Systems Inc. (Nasdaq – VRNT), Dayforce, Inc. (NYSE – DAY), WideOpenWest, Inc. (NYSE – WOW), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
4 months ago - By: Benzinga
A Look Ahead: Y-mAbs Therapeutics's Earnings Forecast
3 months ago - By: Halper Sadeh LLC
- Mentions:
DAY
WOW
STAA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders
3 months ago - By: Brodsky & Smith LLC
- Mentions:
DAY
WOW
STAA
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
3 months ago - By: Halper Sadeh LLC
- Mentions:
VBTX
TASK
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, TASK, YMAB on Behalf of Shareholders
3 months ago - By: Kahn Swick & Foti, LLC
Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
3 months ago - By: Brodsky & Smith LLC
- Mentions:
WOW
BFIN
STAA
FFBC
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
3 months ago - By: Benzinga
- Mentions:
MBC
AMWD
BA
COP
...
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
3 months ago - By: Ademi & Fruchter LLP
Shareholder Alert: The Ademi Firm Investigates Whether Y-mAbs Therapeutics Inc. is Obtaining a Fair Price for its Public Shareholders
3 months ago - By: The Motley Fool
Y-mAbs (YMAB) Q2 Revenue Falls 14%
3 months ago - By: Y-mAbs Therapeutics, Inc.
Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
3 months ago - By: Zacks Investment Research
- Mentions:
CLDX
Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
4 months ago - By: Kahn Swick & Foti, LLC
Y-MABS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
4 months ago - By: Y-mAbs Therapeutics, Inc.
Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
4 months ago - By: Zacks Investment Research
- Mentions:
KROS
Keros Therapeutics, Inc. (KROS) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Halper Sadeh LLC
- Mentions:
STAA
BASE
CORZ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, BASE, CORZ on Behalf of Shareholders
4 months ago - By: Brodsky & Smith LLC
- Mentions:
STAA
BASE
CORZ
ALC
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)
4 months ago - By: Ademi LLP
Shareholder Alert: The Ademi Firm investigates whether Y-mAbs Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
4 months ago - By: Halper Sadeh LLC
YMAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Y-mAbs Therapeutics, Inc. Is Fair to Shareholders
4 months ago - By: Y-mAbs Therapeutics, Inc.
SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
Please enable JavaScript to continue using this application.